The U.S. Food and Drug Administration (FDA) has approved updated versions of the COVID-19 vaccines from Pfizer and Moderna, but has limited eligibility to high-risk groups....
As autumn approaches, many individuals are starting to experience the onset of fall allergies. With cooler mornings signaling the change of seasons, millions are already facing...
After ten years and an expenditure of over $30 million, the Washington State Department of Labor & Industries (L&I) has suspended its efforts to modernize the...
Recognizing the potential benefits of stress can lead to improved mental well-being. In the latest installment of the “Wellness Your Way” series, pediatrician Dr. Yolanda Rivera-Caudill...
The European Commission (EC) has granted approval for tislelizumab (Tevimbra) as a combination treatment for adults with resectable non-small cell lung cancer (NSCLC) at high risk...
Reviva Pharmaceuticals Inc. has made significant strides in developing a new treatment for schizophrenia, a complex brain disorder that affects approximately 24 million people worldwide, including...
Reviva Pharmaceuticals Inc. has made significant progress in the development of a novel drug aimed at treating schizophrenia, a complex brain disorder affecting approximately 24 million...
Food safety inspections conducted by the **Montgomery County Office of Public Health** between August 17 and 23, 2025, revealed alarming violations across several food establishments. Notably,...
A woman grapples with the aftermath of her husband’s emotional affair, seeking advice on how to restore trust in their marriage. The situation escalated when she...
Titan Pharmaceuticals, Inc. experienced a remarkable surge in its stock price, rising 23% in after-hours trading on Tuesday, reaching $6.15 per share. This increase followed the...
